Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tn MUC1 CAR T-cell therapy / Gilead
CART-TnMUC1-01, NCT04025216: A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers Jul 2021 - Dec 2021 : Data from trial for solid tumors	Terminated	1	16	US	CART-TnMUC1, Cyclophosphamide, Fludarabine	Gilead Sciences	Non-Small Cell Lung Cancer, Ovarian Cancer, Fallopian Tube Cancer, Triple Negative Breast Cancer, Multiple Myeloma, Pancreatic Ductal Adenocarcinoma	12/22	12/22